BE530825A - - Google Patents
Info
- Publication number
- BE530825A BE530825A BE530825DA BE530825A BE 530825 A BE530825 A BE 530825A BE 530825D A BE530825D A BE 530825DA BE 530825 A BE530825 A BE 530825A
- Authority
- BE
- Belgium
- Prior art keywords
- streptomycin
- solutions
- solution
- agent
- salts
- Prior art date
Links
- UCSJYZPVAKXKNQ-HZYVHMACSA-N 1-[(1S,2R,3R,4S,5R,6R)-3-carbamimidamido-6-{[(2R,3R,4R,5S)-3-{[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 78
- 239000000243 solution Substances 0.000 claims description 71
- 229960005322 Streptomycin Drugs 0.000 claims description 33
- 239000003381 stabilizer Substances 0.000 claims description 16
- PJUIMOJAAPLTRJ-GSVOUGTGSA-N (R)-monothioglycerol Chemical compound OC[C@@H](O)CS PJUIMOJAAPLTRJ-GSVOUGTGSA-N 0.000 claims description 10
- 239000011780 sodium chloride Substances 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K Trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 238000002845 discoloration Methods 0.000 claims description 7
- 239000001509 sodium citrate Substances 0.000 claims description 7
- 239000011778 trisodium citrate Substances 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 4
- 239000006172 buffering agent Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 3
- 150000001299 aldehydes Chemical class 0.000 claims description 3
- 230000001954 sterilising Effects 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- 229960002385 Streptomycin Sulfate Drugs 0.000 description 11
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 8
- 229940001607 sodium bisulfite Drugs 0.000 description 8
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- AWBXTNNIECFIHT-XZQQZIICSA-N 2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;2-[(1R,2R,3S,4R,5R,6S)-3-( Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O AWBXTNNIECFIHT-XZQQZIICSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000003115 biocidal Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- CZWJCQXZZJHHRH-YCRXJPFRSA-N 2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;sulfuric acid Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O CZWJCQXZZJHHRH-YCRXJPFRSA-N 0.000 description 2
- 229960001162 Dihydrostreptomycin Sulfate Drugs 0.000 description 2
- XWGJFPHUCFXLBL-UHFFFAOYSA-M Rongalite Chemical compound [Na+].OCS([O-])=O XWGJFPHUCFXLBL-UHFFFAOYSA-M 0.000 description 2
- JVBXVOWTABLYPX-UHFFFAOYSA-L Sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 2
- 229920002892 amber Polymers 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 230000002335 preservative Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229940049954 Penicillin Drugs 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical class N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L Potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 229960000626 benzylpenicillin Drugs 0.000 description 1
- 229960002222 dihydrostreptomycin Drugs 0.000 description 1
- ASXBYYWOLISCLQ-HZYVHMACSA-N dihydrostreptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O ASXBYYWOLISCLQ-HZYVHMACSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002349 favourable Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- PYOZTOXFQNWBIS-UHFFFAOYSA-N phenol;sodium Chemical compound [Na].OC1=CC=CC=C1 PYOZTOXFQNWBIS-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001698 pyrogenic Effects 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing Effects 0.000 description 1
- -1 streptomycin sulphates Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE530825A true BE530825A (xx) |
Family
ID=163364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE530825D BE530825A (xx) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE530825A (xx) |
-
0
- BE BE530825D patent/BE530825A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0682944B1 (fr) | Formulation stable lyophilisée comprenant une protéine; kit de dosage | |
| CA2233924C (fr) | Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation | |
| JP5108517B2 (ja) | 治療活性剤、クエン酸または共役塩基、および二酸化塩素を含む安定化された組成物 | |
| FR2604906A1 (fr) | Collyre | |
| FR2665635A1 (fr) | Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation. | |
| BE1003647A5 (fr) | Composition pharmaceutique de nicardipine pour administration parenterale. | |
| EP1343473B1 (fr) | Composition pharmaceutique de dronedarone pour administration parenterale | |
| EP0244315B1 (fr) | Procédé de préparation d'une solution pharmaceutique aqueuse d'un principe actif constitué par un acide organique | |
| JP4278322B2 (ja) | 水溶性クロロヘキシジン含有の粉体状、顆粒状又は錠剤状の組成物、該組成物の製造法及びその使用 | |
| BE1001527A6 (fr) | Preparation aqueuse stabilisee d'acide folique. | |
| FR2779061A1 (fr) | Nouveau procede de stabilisation de composes phenoliques et les compositions pharmaceutiques en resultant | |
| CH644015A5 (fr) | Solution aqueuse injectable a base d'oxytetracycline. | |
| BE1004051A4 (fr) | Solution injectable et procede pour la preparer. | |
| BE530825A (xx) | ||
| EP2489347A1 (fr) | Procédé de production de formes injectables de phloroglucinol, et les formes injectables ainsi réalisées | |
| CH635487A5 (fr) | Procede de fabrication de gommes a macher. | |
| EP0830144B1 (fr) | Compositions pulverulentes et solubles dans l'eau et leurs applications | |
| EP0069674A1 (fr) | Médicaments contenant une N-acyl-L-aspartyl-taurine | |
| FR2461463A1 (fr) | Procede de preparation d'eaux minerales ferrugineuses, eaux minerales obtenues par ce procede et leurs applications therapeutiques | |
| EP0575481A1 (fr) | Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4. | |
| CA2396180C (fr) | Solution aqueuse stable de deoxyfructosazine | |
| BE536866A (xx) | ||
| CH326787A (fr) | Procédé de fabrication de préparations injectables d'insuline à effet prolongé | |
| BE572443A (xx) | ||
| BE530472A (xx) |